Cocoon animatie

0:00
Video Narration
6
0

Description

Research on Cancer

Vocal Characteristics

Language

English

Voice Age

Middle Aged (35-54)

Accents

North American (General) North American (US General American - GenAM)

Transcript

Note: Transcripts are generated using speech recognition software and may contain errors.
At Galapagos. It is our call for purpose to improve the quality of life of patients and to bring innovation to our key areas of expertise like oncology and immunology. Let's zoom in on oncology. Our researchers are developing next generation cancer treatments. This is Tim, an ordinary T cell T cells like Tim play an important role in our body's defense against cancer. But we have even bigger plans in store for Tim. He's about to get his call for purpose. A T cell that looks like this picture makes a noise. That sounds like me. Yes, Tim. You, are you ready for a serious upgrade in car T cell therapy T cells like Tim are extracted from the patient's blood and genetically modified the T cells receive the genetic recipe for making chimeric antigen receptors called car. In short, this will help them to recognize the cancer cells. And so T cells like Tim become car T cells. These car T cells are fully equipped to target the cancer cells so they can find and destroy them. Now, Tim is infused back into the patient's blood together with millions car T cells like him ready to fight cancer since the manufacturing of car T cells is highly complex, the cells of the patient are transported to and from special factories. While current car T treat treatments can be life saving long lead times. Central manufacturing and complex logistics are current limiting factors for large scale capacity and broad patient access. And there it is Galapagos call for purpose. We are innovating the next step in car T cell therapy. A decentralized model. This model allows us to manufacture car cells at the point of care close to patients in the future. This can help us to give patients the treatment they need in a much shorter period of time. But our decentralized model does not only aim for shortening the waiting time for patients to get their treatment. It also has the potential to treat many more in need. Innovations like these bring us closer to patients. They show our commitment to accelerating transformational medicines to give patients. What matters most, more time with family and friends, more joy, a longer healthier and better quality life. And that is our call for purpose. Is it yours too?